questionsmedicales.fr
Phénomènes chimiques
Phénomènes biochimiques
Conformation moléculaire
Conformation des protéines
Éléments structuraux des protéines
Motifs et domaines d'intéraction protéique
Motifs et domaines d'intéraction protéique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Motifs et domaines d'intéraction protéique : Questions médicales les plus fréquentes",
"headline": "Motifs et domaines d'intéraction protéique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Motifs et domaines d'intéraction protéique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éléments structuraux des protéines",
"url": "https://questionsmedicales.fr/mesh/D000072416",
"about": {
"@type": "MedicalCondition",
"name": "Éléments structuraux des protéines",
"code": {
"@type": "MedicalCode",
"code": "D000072416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine B30.2-SPRY",
"alternateName": "B30.2-SPRY Domain",
"url": "https://questionsmedicales.fr/mesh/D000071197",
"about": {
"@type": "MedicalCondition",
"name": "Domaine B30.2-SPRY",
"code": {
"@type": "MedicalCode",
"code": "D000071197",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine BTB-POZ",
"alternateName": "BTB-POZ Domain",
"url": "https://questionsmedicales.fr/mesh/D000071757",
"about": {
"@type": "MedicalCondition",
"name": "Domaine BTB-POZ",
"code": {
"@type": "MedicalCode",
"code": "D000071757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.343"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Superfamille des domaines de mort",
"alternateName": "Death Domain Superfamily",
"url": "https://questionsmedicales.fr/mesh/D000071458",
"about": {
"@type": "MedicalCondition",
"name": "Superfamille des domaines de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine d'activation et de recrutement des caspases",
"alternateName": "Caspase Activation and Recruitment Domain",
"url": "https://questionsmedicales.fr/mesh/D000071476",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'activation et de recrutement des caspases",
"code": {
"@type": "MedicalCode",
"code": "D000071476",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine de mort",
"alternateName": "Death Domain",
"url": "https://questionsmedicales.fr/mesh/D000071459",
"about": {
"@type": "MedicalCondition",
"name": "Domaine de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071459",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine effecteur de mort",
"alternateName": "Death Effector Domain",
"url": "https://questionsmedicales.fr/mesh/D000071461",
"about": {
"@type": "MedicalCondition",
"name": "Domaine effecteur de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine pyrine",
"alternateName": "Pyrin Domain",
"url": "https://questionsmedicales.fr/mesh/D000071196",
"about": {
"@type": "MedicalCondition",
"name": "Domaine pyrine",
"code": {
"@type": "MedicalCode",
"code": "D000071196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Domaines FERM",
"alternateName": "FERM Domains",
"url": "https://questionsmedicales.fr/mesh/D000075926",
"about": {
"@type": "MedicalCondition",
"name": "Domaines FERM",
"code": {
"@type": "MedicalCode",
"code": "D000075926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines MYND",
"alternateName": "MYND Domains",
"url": "https://questionsmedicales.fr/mesh/D000074608",
"about": {
"@type": "MedicalCondition",
"name": "Domaines MYND",
"code": {
"@type": "MedicalCode",
"code": "D000074608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.474"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines PDZ",
"alternateName": "PDZ Domains",
"url": "https://questionsmedicales.fr/mesh/D054731",
"about": {
"@type": "MedicalCondition",
"name": "Domaines PDZ",
"code": {
"@type": "MedicalCode",
"code": "D054731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines à doigts de zinc de type RING",
"alternateName": "RING Finger Domains",
"url": "https://questionsmedicales.fr/mesh/D054829",
"about": {
"@type": "MedicalCondition",
"name": "Domaines à doigts de zinc de type RING",
"code": {
"@type": "MedicalCode",
"code": "D054829",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine d'homologie SRC",
"alternateName": "src Homology Domains",
"url": "https://questionsmedicales.fr/mesh/D018909",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'homologie SRC",
"code": {
"@type": "MedicalCode",
"code": "D018909",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Motif stérile alpha",
"alternateName": "Sterile Alpha Motif",
"url": "https://questionsmedicales.fr/mesh/D000071682",
"about": {
"@type": "MedicalCondition",
"name": "Motif stérile alpha",
"code": {
"@type": "MedicalCode",
"code": "D000071682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine Tudor",
"alternateName": "Tudor Domain",
"url": "https://questionsmedicales.fr/mesh/D000071856",
"about": {
"@type": "MedicalCondition",
"name": "Domaine Tudor",
"code": {
"@type": "MedicalCode",
"code": "D000071856",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines WW",
"alternateName": "WW Domains",
"url": "https://questionsmedicales.fr/mesh/D000074585",
"about": {
"@type": "MedicalCondition",
"name": "Domaines WW",
"code": {
"@type": "MedicalCode",
"code": "D000074585",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique",
"alternateName": "Protein Interaction Domains and Motifs",
"code": {
"@type": "MedicalCode",
"code": "D054730",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ylva Ivarsson",
"url": "https://questionsmedicales.fr/author/Ylva%20Ivarsson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry-BMC, Uppsala University, Box 576, SE-751 23 Uppsala, Sweden. Electronic address: Yiva.ivarson@kemi.uu.se."
}
},
{
"@type": "Person",
"name": "Sobia Idrees",
"url": "https://questionsmedicales.fr/author/Sobia%20Idrees",
"affiliation": {
"@type": "Organization",
"name": "School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Keshav Raj Paudel",
"url": "https://questionsmedicales.fr/author/Keshav%20Raj%20Paudel",
"affiliation": {
"@type": "Organization",
"name": "Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Per Jemth",
"url": "https://questionsmedicales.fr/author/Per%20Jemth",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Biochemistry and Microbiology, Uppsala University, BMC Box 582, SE-75123 Uppsala, Sweden. Electronic address: Per.Jemth@imbim.uu.se."
}
},
{
"@type": "Person",
"name": "Norman E Davey",
"url": "https://questionsmedicales.fr/author/Norman%20E%20Davey",
"affiliation": {
"@type": "Organization",
"name": "Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "jmBIG: enhancing dynamic risk prediction and personalized medicine through joint modeling of longitudinal and survival data in big routinely collected data.",
"datePublished": "2024-08-06",
"url": "https://questionsmedicales.fr/article/39107693",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-024-02289-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Data Suppression Rules on Data Access and Re-Identification Risk in Adoption and Foster Care Analysis and Reporting System Annual Files.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10775595241270042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systematic data quality assessment of electronic health record data to evaluate study-specific fitness: Report from the PRESERVE research study.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38935590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pdig.0000527"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data Preprocessing Techniques for Artificial Learning (AI)/Machine Learning (ML)-Readiness: Systematic Review of Wearable Sensor Data in Cancer Care.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38626290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/59587"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Comparison of hospital rating websites among each other and with data from hospital quality reports and quality assurance based on routine data].",
"datePublished": "2024-01-24",
"url": "https://questionsmedicales.fr/article/38265488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02263-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes chimiques",
"item": "https://questionsmedicales.fr/mesh/D055598"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes biochimiques",
"item": "https://questionsmedicales.fr/mesh/D001669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Conformation moléculaire",
"item": "https://questionsmedicales.fr/mesh/D008968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Conformation des protéines",
"item": "https://questionsmedicales.fr/mesh/D011487"
},
{
"@type": "ListItem",
"position": 6,
"name": "Éléments structuraux des protéines",
"item": "https://questionsmedicales.fr/mesh/D000072416"
},
{
"@type": "ListItem",
"position": 7,
"name": "Motifs et domaines d'intéraction protéique",
"item": "https://questionsmedicales.fr/mesh/D054730"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Motifs et domaines d'intéraction protéique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Motifs et domaines d'intéraction protéique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Motifs et domaines d'intéraction protéique",
"description": "Comment identifier un domaine d'interaction protéique ?\nQuels tests sont utilisés pour analyser les interactions protéiques ?\nLes motifs d'interaction peuvent-ils être prédits ?\nQuels marqueurs indiquent une interaction protéique ?\nComment les mutations affectent-elles les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Motifs et domaines d'intéraction protéique",
"description": "Quels symptômes indiquent une dysfonction protéique ?\nLes interactions protéiques peuvent-elles causer des maladies ?\nComment les maladies génétiques affectent-elles les interactions ?\nQuels signes cliniques sont liés aux troubles d'interaction ?\nLes infections peuvent-elles perturber les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Motifs et domaines d'intéraction protéique",
"description": "Comment prévenir les maladies liées aux interactions protéiques ?\nLes dépistages sont-ils utiles pour les troubles protéiques ?\nL'éducation sur les interactions protéiques est-elle importante ?\nLes vaccins influencent-ils les interactions protéiques ?\nComment le stress affecte-t-il les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Motifs et domaines d'intéraction protéique",
"description": "Quels traitements ciblent les interactions protéiques ?\nComment la thérapie génique influence-t-elle les interactions ?\nLes inhibiteurs de protéines sont-ils efficaces ?\nComment les traitements ciblent-ils les motifs d'interaction ?\nLes thérapies combinées sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Motifs et domaines d'intéraction protéique",
"description": "Quelles complications peuvent survenir avec des interactions anormales ?\nLes complications sont-elles réversibles ?\nComment les interactions affectent-elles le vieillissement ?\nLes maladies auto-immunes sont-elles liées aux interactions ?\nLes troubles métaboliques sont-ils causés par des interactions ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Motifs et domaines d'intéraction protéique",
"description": "Quels facteurs augmentent le risque de troubles protéiques ?\nLe vieillissement est-il un facteur de risque ?\nLes infections virales influencent-elles les interactions ?\nLe mode de vie peut-il affecter les interactions protéiques ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Data+Visualization&page=997#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un domaine d'interaction protéique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par des méthodes bioinformatiques et des expériences de biologie moléculaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les interactions protéiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le co-immunoprécipitation et les essais de double hybride."
}
},
{
"@type": "Question",
"name": "Les motifs d'interaction peuvent-ils être prédits ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des outils bioinformatiques permettent de prédire les motifs d'interaction dans les protéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent une interaction protéique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de conformation ou des complexes protéiques stables peuvent indiquer une interaction."
}
},
{
"@type": "Question",
"name": "Comment les mutations affectent-elles les interactions protéiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent altérer la structure des motifs, perturbant ainsi les interactions normales."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction protéique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme la fatigue, des troubles métaboliques ou des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les interactions protéiques peuvent-elles causer des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent contribuer à des maladies comme le cancer ou Alzheimer."
}
},
{
"@type": "Question",
"name": "Comment les maladies génétiques affectent-elles les interactions ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des défauts dans les motifs d'interaction, perturbant les fonctions cellulaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont liés aux troubles d'interaction ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'inflammation, la douleur ou des anomalies neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles perturber les interactions protéiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains pathogènes modifient les interactions protéiques pour favoriser leur survie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux interactions protéiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages sont-ils utiles pour les troubles protéiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages précoces peuvent aider à identifier des risques de maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les interactions protéiques est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les interactions peut aider à prévenir des maladies et à promouvoir la santé."
}
},
{
"@type": "Question",
"name": "Les vaccins influencent-ils les interactions protéiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent moduler les interactions immunitaires, renforçant la réponse du corps."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il les interactions protéiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut altérer les interactions protéiques, affectant la santé globale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les interactions protéiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de protéines ou des anticorps monoclonaux sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique influence-t-elle les interactions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut corriger des mutations, rétablissant ainsi des interactions protéiques normales."
}
},
{
"@type": "Question",
"name": "Les inhibiteurs de protéines sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent bloquer des interactions spécifiques, offrant des options thérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment les traitements ciblent-ils les motifs d'interaction ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils visent à modifier ou à bloquer des motifs spécifiques pour restaurer la fonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent cibler plusieurs interactions protéiques, améliorant l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des interactions anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des cancers, des maladies neurodégénératives ou des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les interactions affectent-elles le vieillissement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interactions protéiques altérées peuvent accélérer le vieillissement cellulaire et tissulaire."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles liées aux interactions ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent déclencher des réponses auto-immunes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils causés par des interactions ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions protéiques défectueuses peuvent entraîner des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles protéiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la génétique, l'environnement et le mode de vie influencent le risque."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la stabilité et la fonction des interactions protéiques."
}
},
{
"@type": "Question",
"name": "Les infections virales influencent-elles les interactions ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber les interactions protéiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les interactions protéiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée et le manque d'exercice peuvent altérer les interactions."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des toxines ou des polluants peuvent affecter les interactions protéiques et la santé."
}
}
]
}
]
}
We have introduced the R package jmBIG to facilitate the analysis of large healthcare datasets and the development of predictive models. This package provides a comprehensive set of tools and function...
One of the most widely used data sources for research on foster care and adoption is the Adoption and Foster Care Analysis and Reporting System (AFCARS). County identifiers in AFCARS are suppressed fo...
Study-specific data quality testing is an essential part of minimizing analytic errors, particularly for studies making secondary use of clinical data. We applied a systematic and reproducible approac...
Wearable sensors are increasingly being explored in healthcare, including in cancer care, for their potential in continuously monitoring patients. Despite their growing adoption, significant challenge...
The aim of this study was to conduct a systematic review of preprocessing techniques employed on wearable sensor data to ensure their readiness for artificial intelligence/machine learning ("AI/ML-rea...
We systematically searched IEEE Xplore, PubMed, Embase (including Embase, Embase Classic, MEDLINE, PubMed-not-MEDLINE), and Scopus to identify potentially relevant studies for this review. The eligibi...
In the initial phase, 2,147 papers were identified between January 2018-December 2023. After a thorough evaluation of these selected papers, we applied our predefined eligibility criteria, which resul...
While wearable sensors are gaining traction in cancer care, there remain challenges in the application of standard AI/ML techniques due to low quality of raw data captured and not applying appropriate...
In addition to the objectifiable treatment quality, patients' perspectives are gaining relevance....
This study aimed to characterize available hospital rating websites (HRW) with regards to patient ratings and to compare them with data from hospital quality reports and quality assurance based on rou...
After a structured online search for HRWs, websites were compared based on patient ratings from the 10 urologic departments with the largest intervention rates in 2021 using generalized estimated equa...
Of 1845 hits, 25 portals were analyzed. The department-wise comparison of HRWs resulted in significantly different patient ratings (p < 0.001). Patient ratings (klinikbewertungen.de) and QSR data (AOK...
Hospital rating websites show considerable heterogeneity regarding patient ratings of the same urology department in different portals. Furthermore, based on the selected examples, there seems to be n...
This paper discusses how collective intelligence (CI) methods can be implemented to improve government data infrastructures, not only to support understanding and primary use of complex national data ...
A stakeholder-engaged CI approach was applied to inform the transformation of the NILS Research Support Unit (RSU) infrastructure to support researchers in their use of government data, including coll...
We provide an overview of NILS RSU infrastructure design changes that have been implemented to date, focusing on a website redesign to meet user information requirements and the formation of better wo...
Our primary objective to improve government data infrastructure and to increase dissemination and the impact of research based on data was a complex and multifaceted challenge due to the number of sta...
This study compares the clinical and haemodynamic severity of methamphetamine-associated pulmonary arterial hypertension (MA-PAH) with idiopathic pulmonary arterial hypertension (IPAH) and connective ...
This is a cross-sectional study using clinically derived data from the National Biological Sample and Data Repository for Pulmonary Arterial Hypertension (PAH biobank), a US-based registry, to compare...
The analysis included 1830 patients enrolled in the PAH biobank, with a diagnosis of MA-PAH (n=42), IPAH (n=1073), or CTD-PAH (n=715)....
The study assessed and compared the clinical and haemodynamic parameters of patients with MA-PAH, IPAH and CTD-PAH....
Among the patients analysed, 42 had MA-PAH, with 69.1% being female. There were no statistically significant differences in functional class among patients with MA-PAH, IPAH and CTD-PAH. The per cent ...
There were no differences in haemodynamic between MA-PAH and IPAH but we found that MA-PAH differed from CTD-PAH. The study did not find evidence of sex differences in MA-PAH. Further research is nece...
Low birthweight (<2500 g) and preterm birth (<37 weeks) are markers of newborn vulnerability. To facilitate informed decisions about investments in prevention and care, it is imperative to enhance dat...
Systematic data quality assessment by adopting the WHO Data Quality Framework....
National routine data system from UN member states....
Livebirths....
National routine administrative data on low birthweight and preterm births for 195 countries from 2000 to 2020 were systematically collated, totalling >700 million live births. The WHO data quality fr...
Availability, reporting quality, internal and external consistency of low birthweight and preterm data....
Most United States Member States (64%: 124/195) had national data on low birthweight and (40%: 82/195) had data on preterm birth. Routine data system reporting was highest in North America, Australasi...
Sub-Saharan Africa and South Asia countries have data gaps but also opportunities for rapid progress. Most births occure in facilities, electronic health information systems already include low birthw...
Sales data analyses are increasingly used to guide tobacco regulatory science. However, such data do not cover specialist retailers like vape shops or tobacconists. Understanding the extent of the cig...
Sales data from Information Resources Incorporated (IRI) and Nielsen Retail Scanner data are used to conduct a tax gap analysis, comparing state tax collections based on cigarette and ENDS sales data ...
Across states covered by both sales datasets, IRI's mean cigarette sales coverage was 92.3% (95% CI 88.3-96.2%), while Nielsen's was 84.0% (95% CI 79.3-88.7%). Coverage rates for average ENDS sales we...
IRI and Nielsen sales data capture almost the entire US cigarette market and, while coverage rates are lower, a substantial portion of the US market for ENDS as well. Coverage rates are relatively sta...
Many medical errors occur in the process of treating cardiovascular patients, and most of these errors are related to prescription errors. There are several, one of the methods to prevent prescription...